Search

everythinglearnresearchcommunity

for

Search:↓

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

The document concludes that freeze-dried platelet-rich plasma shows promise for medical use but requires standardization and further research.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

FUE hair transplants offer minimal scarring and are good for short hairstyles but are time-consuming and can be costly.

The article concludes that the global hair trade is exploitative and reflects complex cultural and economic issues.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Hair-thread Tourniquet Syndrome, where hair or thread tightly wraps around a body part, is not rare and requires early detection to prevent serious damage.

Early hair loss may indicate prostate issues.

Genetic marker rs12558842 strongly linked to male hair loss.

Astaxanthin is a safe antioxidant that may improve heart, skin, eye health, and physical performance, and help manage chronic diseases.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

New drugs for heart disease may be developed from molecules secreted by stem cells.

Premature hair graying in young Turkish adults is more likely if they have stress, a family history of graying, drink alcohol, have chronic diseases, are older, or are taller.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Testosterone improves mood and thinking skills; finasteride has no effect.

Using neurohormones to control keratin can lead to new skin disease treatments.

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.